Sleeping between 10 and 11 p.m. may cut risk for cardiovascular disease: ESC study Hina Zahid10 Nov 2021 10:00 PM ISTGoing to sleep between 10:00 and 11:00 pm is associated with a lower risk of developing heart disease compared to earlier or later bedtimes. Sleeping...
Iron deficiency in midlife tied to higher risk of developing CAD: ESC study Dr Kartikeya Kohli6 Oct 2021 10:00 AM ISTSophia-Antipolis: Iron deficiency during middle age may be associated with higher risk of coronary heart disease, finds a new study.Approximately 10%...
Quitting smoking after heart attack linked to improved mood: Study Dr. Kamal Kant Kohli9 Sept 2021 9:00 AM ISTFrance: Heart attack survivors who quit smoking are more likely to have improved mood than those who continue the habit, that's the conclusion from a...
Green neighborhoods linked to lower risk of cardiovascular disease: Study Dr. Kamal Kant Kohli9 Sept 2021 9:00 AM ISTTree planting and greening of neighborhoods are associated with multiple benefits and offer a relatively low-cost investment to enhance health and...
Study supports use of implantable cardiac monitors in selected post-infarction patients Dr. Kamal Kant Kohli7 Sept 2021 9:00 AM ISTSophia Antipolis: Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of serious arrhythmias in...
Drinking sufficient water could reduce risk of heart failure: Study Hina Zahid1 Sept 2021 9:00 AM ISTSophia Antipolis, France - Staying well hydrated throughout life could reduce the risk of developing heart failure, according to research...
Study observes steep increase in opioid-related cardiac arrest cases Medha Baranwal30 Aug 2021 9:00 AM ISTThe study found a significant increasing trend in opioid-associated cardiac arrest over the seven-year period.USA: There is a steep rise in...
Evolocumab Improves Features Of Plaque Stability In patients of ACS: HUYGENS trial Medical Dialogues Bureau30 Aug 2021 6:15 AM ISTUSA: Repatha (evolocumab) in addition to optimized statin therapy, in comparison with optimized statin therapy alone, significantly improved features...
Empagliflozin significantly reduces hospitalization risk in patients of HFpEF, shows trial Dr. Kamal Kant Kohli30 Aug 2021 6:00 AM ISTFrance: SGLT-2 inhibitor, Empagliflozin significantly reduced heart failure-related hospitalizations, regardless of patient diabetes status, reveal...
Heart patients need more help to lose weight, finds ESC study Hina Zahid12 Aug 2021 9:00 AM ISTSophia Antipolis: Weight loss is given insufficient priority in the management of heart patients despite the benefits, according to a study...
Dietary recommendations to prevent atherosclerosis and heart disease: ESC Hina Zahid12 July 2021 7:04 PM ISTFor fruits and vegetables, given their strong association with a lower risk of atherosclerosis, daily consumption should be increased to as much as...
EMPEROR-Preserved confirms success of Empagliflozin in HFpEF Hina Zahid8 July 2021 9:45 AM ISTEmpagliflozin therapy with specific benefits in patients with heart failure and preserved ejection fraction (HFpEF) may finally be on its way as the...
